Tumor necrosis factor α modulates parathyroid hormone action in UMR-106–01 osteoblastic cells
Open Access
- 1 October 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (10) , 1191-1200
- https://doi.org/10.1002/jbmr.5650081006
Abstract
Tumor necrosis factor (TNF-α) has been shown to play an important role in local control of bone remodeling. The interaction of TNF-α and PTH was evaluated in UMR-106–01 cells, a phenotypic osteoblastic osteosarcoma cell line. We examined the influence of TNF-α on the two signal transduction systems triggered by PTH in UMR-106–01 cells, adenylate cyclase and free cytosolic calcium ([Ca2+]i). cAMP generation was inhibited in TNF-α-pretreated cells by 69, 61, 34, and 21% at PTH concentrations of 0.1, 1, 10, and 100 nM, respectively. Inhibition was seen at TNF-α doses of 100–1500 units/ml after a minimum incubation time of 12 h. TNF-α inhibition of the PTH-stimulated increase in [Ca2+], was even more pronounced: treated cells showed no change in baseline [Ca2+]i, after stimulation with 40 nM PTH. Treatment with TNF-α was also found to inhibit both arms of the PTH response in the nontransformed osteoblastic cell line, MC3T3-El. TNF-α treatment did not alter cAMP generation in response to PGE2. TNF-α inhibition of the PTH-stimulated cAMP response was reversed completely by addition of cholera toxin (5 μg/ml) and partially by forskolin (10 μM) but not pertussis toxin (100 and 500 ng/ml). Scatchard analysis using PTHrP revealed that TNF-α treatment reduced the number of receptors but had no effect on KD. These findings suggest that TNF-α inhibits the osteoblastic response to PTH at least in part because of a reduction in receptor number. Further investigation is indicated to provide insight into the interaction of calciotropic hormones and cytokines in vivo.Keywords
Funding Information
- National Research Service Award (1F32GM3515-01)
- Career Development Award and Medical Research
This publication has 40 references indexed in Scilit:
- Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone‐responsive adenylate cyclase in clonal osteoblast‐like cell by down‐regulating parathyroid hormone receptorsJournal of Cellular Physiology, 1992
- Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase CBiochemical and Biophysical Research Communications, 1992
- Prostaglandins enhance parathyroid hormone-evoked increase in free cytosolic calcium concentration in osteoblast-like cellsCell Calcium, 1991
- Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitroJournal of Bone and Mineral Research, 1989
- Growth factors and the regulation of bone remodeling.Journal of Clinical Investigation, 1988
- Different roles for calcium and cyclic AMP in the action of PTH: Studies in bone explants and isolated bone cellsBone, 1988
- Inhibition by tumor necrosis factor of induction of ectopic bone formation by osteosarcoma-derived bone-inducing substanceBone, 1988
- Tumor necrosis factor type α (cachectin) stimulates mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2Biochemical and Biophysical Research Communications, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985